Data-Driven Market Expansion
for Infusion Organizations
Where should you open your next infusion center or home infusion territory? SolisRx replaces expansion guesses with analytics: demand modeling, competitive mapping, and referral network intelligence that tells you where growth will stick.
40+
Companies Advised
Why Most Infusion Expansion Decisions Rely on Incomplete Data
Your board approved a six-site expansion modeled on current-site averages. Six months after opening, the new site runs at 38 percent capacity. Referrals are below projection, payer mix skewing Medicare-heavy, two competitors with deep physician relationships already in market.
This is common among ambulatory infusion centers, home infusion providers, and specialty pharmacies that expand on general market signals rather than granular demand analytics. The infusion market is growing rapidly and the question isn’t whether to expand but where. However, every underperforming site drags down blended metrics and consumes management bandwidth.
Our Methodology
DEMAND ANALYSIS
Market claims data from reliable data providers quantifies infusion demand by ZIP code and Census Tracts: total addressable volume, therapy mix (IVIG, biologics, supportive care), and payer mix profile. This tells you whether a market supports a new site at your profitability thresholds.
COMPETITIVE MAPPING
Every infusion provider in each target geography is mapped, from ambulatory infusion centers to hospital outpatient suites, home infusion providers, and specialty pharmacies. The output shows where the field is crowded and where white space opportunities exist.
REFERRAL NETWORK ANALYSIS
Prescriber-level data identifies which physicians are generating infusion referrals, to whom, and for which therapies. Physicians referring to distant facilities or capacity-constrained competitors signal convertible volume, and offers a prioritized referral target list for Sales.
SITE SCORING
Each market receives a composite expansion score integrating demand, payer quality, competitive intensity, and referral accessibility, with a pro forma using claims-derived data, not existing-site averages.
Deliverables
Any engagement is tailored to your specific needs. However, the most common deliverables for AICs, home infusion providers and specialty pharmacies include:
01
Market demand heat map
showing infusion-eligible patient volume, therapy mix, and payer mix by ZIP code.
02
Competitive landscape report
mapping every infusion provider in target markets.
03
Referral network analysis
identifying high-value referring physicians with estimated convertible volume.
04
White space opportunity
map showing geographies where demand exceeds provider capacity.
05
Market-specific financial model
based on claims-derived demand assumptions, capacity analytics, and ramp-up timeline.
06
Composite expansion scorecard
ranking target markets across all evaluation dimensions.
Frequently Asked Questions
How do I know if my infusion organization is ready to expand?
Readiness depends on three factors: operational stability to support a new site, financial capacity to absorb the ramp-up period, and data to identify markets where demand exceeds supply. The third factor is where most operators have a gap. A structured market demand analysis takes four to six weeks and is the minimum diligence step before committing capital.
What data do I need to evaluate a new market?
Core inputs: infusion-eligible patient volume by therapy type and ZIP code, payer mix profile, existing provider capacity, prescriber-level referral patterns, and estimated capture rate based on physician accessibility. The analytical framework connecting these inputs into an expansion decision is what most organizations lack.
How long does it take for a new infusion site to reach capacity?
Well-positioned sites in strong-demand markets reach 70 percent capacity in 9 to 12 months. More competitive markets may take 18 to 24 months. Pre-expansion referral network analysis, prioritizing high-potential physicians before the site opens, has a measurable impact on ramp-up velocity.
Can SolisRx help evaluate service line expansion?
Yes. If you are considering add a new therapy line like IVIG, or entering into a LDN with a specific manufacturer, the same framework applies: demand analysis, referral patterns, and payer reimbursement modeling for that specific therapy category.
What exactly does Stategis deliver?
We deliver tailored strategy, financial modeling, tech audits, and growth planning—backed by real execution support, not just recommendations.
What kind of companies do you typically work with?
We partner with venture-backed startups, scaling tech firms, consulting groups, and finance teams—from pre-seed to Series C and beyond.
Do you offer one-off projects or ongoing advisory?
Both. We offer focused sprints for immediate needs and retainer-based or embedded advisory for longer-term transformation.
How long does it take to get started?
We typically begin within 5–7 business days of your initial call, depending on scope and availability.
Is Stategis a good fit for early-stage startups?
Yes—especially if you’re preparing to raise capital, need a financial model, or want clear systems and priorities before scaling.
What industries do you specialize in?
Our core focus areas are SaaS, fintech, consulting, B2B services, and investment-backed ventures—but we’re flexible if there’s a strategic fit.
How long does it take to get started?
We typically begin within 5–7 business days of your initial call, depending on scope and availability.
What kind of companies do you typically work with?
We partner with venture-backed startups, scaling tech firms, consulting groups, and finance teams—from pre-seed to Series C and beyond.
What exactly does Stategis deliver?
We deliver tailored strategy, financial modeling, tech audits, and growth planning—backed by real execution support, not just recommendations.
Do you offer one-off projects or ongoing advisory?
Both. We offer focused sprints for immediate needs and retainer-based or embedded advisory for longer-term transformation.
Is Stategis a good fit for early-stage startups?
Yes—especially if you’re preparing to raise capital, need a financial model, or want clear systems and priorities before scaling.
What industries do you specialize in?
Our core focus areas are SaaS, fintech, consulting, B2B services, and investment-backed ventures—but we’re flexible if there’s a strategic fit.
